Daratumumab Monotherapy For Patients With Relapsed Or Refractory (R/R) Natural Killer/T-Cell Lymphoma (Nktcl), Nasal Type: Updated Results From An Open-Label, Single-Arm, Multicenter Phase 2 Study
BLOOD（2019）
摘要
Hui-qiang Huang and Won-Seog Kim contributed equally to this work.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要